Skip to main content
Erschienen in: Irish Journal of Medical Science (1971 -) 2/2014

01.06.2014 | Original Article

The effect of a Rapid Access Prostate Cancer Clinic on prostate cancer patient and disease characteristics, primary treatment and surgical workload

verfasst von: S. F. Oon, I. M. Cullen, D. Moran, E. M. Bolton, T. McDermott, R. Grainger, T. H. Lynch

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

In 2009, Rapid Access Prostate Cancer Clinics (RAPC) were introduced to St. James’s Hospital to improve the access and organisation of patients to prostate cancer investigations and treatment.

Aims

To observe the effects of the RAPC on prostate cancer diagnosis, primary treatment and overall workload.

Methods

Using a prospectively designed patient database, the records of all prostate cancer patients between 2007 and 2011 were retrieved and analysed. Data were obtained for age, PSA, biopsy Gleason score and primary treatment modality and charted for the observation and comparison of trends.

Results

Seven hundred and eighty-nine patients had a new diagnosis of prostate cancer between 2007 and 2011. The median PSA prior to the RAPC was 9.7–13.1 ng/ml, which decreased to 7.79–9 ng/ml after the RAPC. Prior to the RAPC, 77–81 biopsies were performed annually versus 149–271 in the post-RAPC era. Annual requirements for radical prostatectomy also increased from 12 to 27 in the post-RAPC era. Conversely, an initially increasing percentage of patients for radiotherapy was reversed in the post-RAPC period. An increasing trend for higher grade PCa (Gleason score 4 + 4 and higher) was also reversed.

Conclusions

The introduction of a RAPC improves the overall pathological characteristics of patients with prostate cancer. However, RAPCs are also associated with a considerable increase in surgical workload. These are important considerations for units considering the incorporation of a similar facility in their institutions.
Literatur
4.
Zurück zum Zitat O’Kelly F, Thomas A, Murray D, Galvin D, Mulvin D, Quinlan DM (2013) Can delayed time to referral to a tertiary level urologist with an abnormal PSA level affect subsequent Gleason grade in the opportunistically screened population? Prostate. doi:10.1002/pros.22628 PubMed O’Kelly F, Thomas A, Murray D, Galvin D, Mulvin D, Quinlan DM (2013) Can delayed time to referral to a tertiary level urologist with an abnormal PSA level affect subsequent Gleason grade in the opportunistically screened population? Prostate. doi:10.​1002/​pros.​22628 PubMed
5.
Zurück zum Zitat Children DoHa (2006) A strategy for cancer control in Ireland—National Cancer Forum 2006. Dublin Children DoHa (2006) A strategy for cancer control in Ireland—National Cancer Forum 2006. Dublin
6.
Zurück zum Zitat Forde JC, O’Connor KM, Casey L, O’Brien M, Bowen S, Casey RG, Ahmed I, McDermott TE, Grainger R, Lynch TH (2011) A rapid access diagnostic clinic for prostate cancer: the experience after one year. Ir J Med Sci 180(2):505–508. doi:10.1007/s11845-011-0695-3 PubMedCrossRef Forde JC, O’Connor KM, Casey L, O’Brien M, Bowen S, Casey RG, Ahmed I, McDermott TE, Grainger R, Lynch TH (2011) A rapid access diagnostic clinic for prostate cancer: the experience after one year. Ir J Med Sci 180(2):505–508. doi:10.​1007/​s11845-011-0695-3 PubMedCrossRef
7.
Zurück zum Zitat O’Kelly F, Thomas AZ, Murray D, Lee P, O’Carroll RF, Nicholson P, Forristal H, Swan N, Galvin D, Mulvin D, Quinlan DM (2013) Emerging evidence for Gleason grade migration and distance impact in prostate cancer? An analysis of the rapid access prostate clinic in a tertiary referral center: St. Vincent’s University Hospital, Dublin (2009-2011). Ir J Med Sci 182(3):487–491. doi:10.1007/s11845-013-0920-3 PubMedCrossRef O’Kelly F, Thomas AZ, Murray D, Lee P, O’Carroll RF, Nicholson P, Forristal H, Swan N, Galvin D, Mulvin D, Quinlan DM (2013) Emerging evidence for Gleason grade migration and distance impact in prostate cancer? An analysis of the rapid access prostate clinic in a tertiary referral center: St. Vincent’s University Hospital, Dublin (2009-2011). Ir J Med Sci 182(3):487–491. doi:10.​1007/​s11845-013-0920-3 PubMedCrossRef
8.
Zurück zum Zitat Hankey BF, Feuer EJ, Clegg LX, Hayes RB, Legler JM, Prorok PC, Ries LA, Merrill RM, Kaplan RS (1999) Cancer surveillance series: interpreting trends in prostate cancer–part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst 91(12):1017–1024PubMedCrossRef Hankey BF, Feuer EJ, Clegg LX, Hayes RB, Legler JM, Prorok PC, Ries LA, Merrill RM, Kaplan RS (1999) Cancer surveillance series: interpreting trends in prostate cancer–part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst 91(12):1017–1024PubMedCrossRef
9.
Zurück zum Zitat Registry NC (2010) Cancer trends—Cancer of the prostate Registry NC (2010) Cancer trends—Cancer of the prostate
10.
Zurück zum Zitat Registry NC (2011) Cancer in Ireland 2011: Annual Report of the National Cancer Registry Registry NC (2011) Cancer in Ireland 2011: Annual Report of the National Cancer Registry
11.
Zurück zum Zitat Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL (2005) The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 29(9):1228–1242PubMedCrossRef Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL (2005) The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 29(9):1228–1242PubMedCrossRef
Metadaten
Titel
The effect of a Rapid Access Prostate Cancer Clinic on prostate cancer patient and disease characteristics, primary treatment and surgical workload
verfasst von
S. F. Oon
I. M. Cullen
D. Moran
E. M. Bolton
T. McDermott
R. Grainger
T. H. Lynch
Publikationsdatum
01.06.2014
Verlag
Springer London
Erschienen in
Irish Journal of Medical Science (1971 -) / Ausgabe 2/2014
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-013-0997-8

Weitere Artikel der Ausgabe 2/2014

Irish Journal of Medical Science (1971 -) 2/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.